Alliancebernstein L.P. Karyopharm Therapeutics Inc. Transaction History

Alliancebernstein L.P.

$278 Billion
Q2 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$1.14 - $1.81 $47,446 - $75,332	-41,620 Reduced 17.75%	192,810 $258,000
Q2 2023 Aug 15, 2023	BUY	$1.79 - $4.59 $101,314 - $259,794	56,600 Added 31.83%	234,430 $419,000
Q1 2023 May 15, 2023	BUY	$2.84 - $3.92 $56,232 - $77,616	19,800 Added 12.53%	177,830 $691,000
Q4 2022 Feb 14, 2023	BUY	$2.48 - $5.93 $49,352 - $118,007	19,900 Added 14.41%	158,030 $537,000
Q3 2022 Nov 15, 2022	BUY	$4.08 - $5.82 $82,008 - $116,982	20,100 Added 17.03%	138,130 $754,000
Q2 2022 Aug 15, 2022	BUY	$4.15 - $8.37 $8,300 - $16,740	2,000 Added 1.72%	118,030 $532,000
Q1 2022 May 13, 2022	BUY	$5.91 - $14.38 $1,182 - $2,876	200 Added 0.17%	116,030 $855,000
Q2 2021 Jul 30, 2021	SELL	$8.11 - $11.11 $112,728 - $154,429	-13,900 Reduced 10.71%	115,830 $1.2 Million
Q3 2020 Nov 12, 2020	SELL	$14.14 - $19.71 $28,280 - $39,420	-2,000 Reduced 1.52%	129,730 $1.89 Million
Q2 2020 Aug 13, 2020	BUY	$16.6 - $25.25 $698,860 - $1.06 Million	42,100 Added 46.97%	131,730 $2.5 Million
Q4 2019 Feb 18, 2020	BUY	$9.23 - $19.67 $11,076 - $23,604	1,200 Added 1.36%	89,630 $1.72 Million
Q3 2019 Nov 14, 2019	SELL	$5.66 - $11.85 $173,762 - $363,795	-30,700 Reduced 25.77%	88,430 $851,000
Q2 2019 Aug 14, 2019	BUY	$4.32 - $6.43 $123,552 - $183,898	28,600 Added 31.59%	119,130 $714,000
Q1 2019 May 14, 2019	BUY	$4.12 - $10.25 $108,768 - $270,600	26,400 Added 41.17%	90,530 $529,000
Q4 2018 Feb 13, 2019	BUY	$8.2 - $16.95 $18,040 - $37,290	2,200 Added 3.55%	64,130 $601,000
Q2 2018 Aug 13, 2018	SELL	$12.0 - $19.88 $128,400 - $212,716	-10,700 Reduced 14.73%	61,930 $1.05 Million
Q1 2018 May 14, 2018	SELL	$9.92 - $17.25 $454,336 - $790,050	-45,800 Reduced 38.67%	72,630 $975,000
Q4 2017 Feb 13, 2018	BUY	$9.15 - $11.99 $686,250 - $899,250	75,000 Added 172.69%	118,430 $1.14 Million
Q3 2017 Nov 13, 2017	BUY	$8.15 - $11.16 $353,954 - $484,678	43,430	43,430 $477,000

Others Institutions Holding KPTI

# of Institutions

120

Shares Held

64.9M

Call Options Held

500K

Put Options Held

99K

Vanguard Group Inc Valley Forge, PA

7.65M
Shares

$6.35 Million
0.0% of portfolio
Palo Alto Investors LP Palo Alto, CA

5.1M
Shares

$4.23 Million
0.56% of portfolio
Eversept Partners, LP New York, NY

4.99M
Shares

$4.14 Million
0.33% of portfolio
Adage Capital Partners Gp, L.L.C. Boston, MA

4.32M
Shares

$3.59 Million
0.01% of portfolio
Black Rock Inc. New York, NY

4.17M
Shares

$3.46 Million
0.0% of portfolio

View Full List

About Karyopharm Therapeutics Inc.

Ticker KPTI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 79,806,600
Market Cap $66.2M
Description
Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases. The company discovers, develops, and commercializes novel and Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and in...

More about KPTI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alliancebernstein L.P. with notifications on news.

Account